Veerle I.j. Bossuyt, M.D.
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Veerle Bossuyt's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Veerle Bossuyt has written about over time.
Carcinoma, EndometrioidMicrosatellite InstabilityReceptor, ErbB-2Antigens, CD20Carcinoma, Ductal, BreastChemotherapy, AdjuvantSpecimen HandlingCarcinoma, Intraductal, NoninfiltratingBreast NeoplasmsLymphocytes, Tumor-InfiltratingPathologyInterdisciplinary CommunicationNeoplasm, ResidualNeoadjuvant TherapyPathology, SurgicalCamptothecin
To see the data from this visualization as text,
click here.
| Name | Number of Publications | First Publication Year | Most Recent Publication Year | Average Publication Date |
|---|
| Carcinoma, Endometrioid | 1 | 2013 | 2013 | April 2013 |
| Microsatellite Instability | 1 | 2013 | 2013 | April 2013 |
| Receptor, ErbB-2 | 8 | 2005 | 2018 | May 2013 |
| Antigens, CD20 | 1 | 2014 | 2014 | September 2014 |
| Carcinoma, Ductal, Breast | 6 | 2009 | 2023 | November 2015 |
| Chemotherapy, Adjuvant | 8 | 2014 | 2020 | August 2016 |
| Specimen Handling | 3 | 2015 | 2017 | September 2016 |
| Carcinoma, Intraductal, Noninfiltrating | 6 | 2009 | 2023 | December 2016 |
| Breast Neoplasms | 39 | 2005 | 2024 | February 2017 |
| Lymphocytes, Tumor-Infiltrating | 7 | 2014 | 2018 | February 2017 |
| Pathology | 2 | 2016 | 2017 | March 2017 |
| Interdisciplinary Communication | 2 | 2016 | 2017 | March 2017 |
| Neoplasm, Residual | 5 | 2015 | 2020 | August 2017 |
| Neoadjuvant Therapy | 14 | 2014 | 2024 | October 2017 |
| Pathology, Surgical | 1 | 2022 | 2022 | June 2022 |
| Camptothecin | 2 | 2023 | 2024 | March 2024 |